After nearly 20 years of development, Shandong Freda Pharmaceutical Group depends on Shandong Academy of Pharmaceutical Sciences technical support, engaged in the human health-related medicines, health food and cosmetics product development, it has become a combined medical R&D agency integrated of science, industry and trade .
Over the years, Freda Group relies on the leading level of bio-engineering technical advantages of China and the United States, it is committed to product development and promotion of biological medicines and related areas, involving many fields including medicine, health food and cosmetics industry, with "Runjie", "Runshu", "Rellte" and other well-known brands. Particularly, Shandong Freda Bio-pharmaceutical Co., Ltd., with the technological advantages of production of hyaluronic acid by fermentation mathod, the products not only occupy a major share of the domestic market but also exported to Japan, the United States, Europe, Korea and other international markets.

Producttion Base:
Freda Pharmaceutical Group has the world's largest R & D base of hyaluronic acid (HA), Asia's largest ophthalmic drug production base, located in Jinan Hi-tech Development Zone, it is a large and combined industrial park integrated of R&D and production.
The company has passed the ISO9001, ISO13485 international quality system certification, in strict accordance with the quality system to manage production which ensures reliability and stability of product quality. Hyaluronate injection has got USA FDA and DMF registration number, quality reached European Pharmacopoeia and Japan Pharmacopoeia standards.